Japan Intellectual Property Rights: COMPOSITIONS AND METHODS FOR TREATING CANCER BY ANTI-ROR1 IMMUNOTHERAPY

Japan, Sept. 16 -- UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES:THE,LENTIGEN TECHNOLOGY INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING CANCER BY ANTI-ROR1 IMMUNOTHERAPY.' Other related details are as follows:

Application Number: JP,2025-094057

Category (FI): A61K35/76,C07K16/28,C07K14/435,C12N15/85@Z,A61K35/17,C12N15/13,A61K31/7088,C12N5/0783,C12N5/10,C12N1/21,C12N1/19,C12N1/15,C12N1/13,C12N15/12,C12N15/62@Z,A61K40/31,A61P35/00,A61P35/02,C12N15/861@Z,C12N15/867@Z,C12N15/869@Z,C07K19/00,A61K48/00,A61K39/395@N,A61K35/761,C12N15/63@Z,C12N15/11@Z

Stage: PROBLEM TO BE SOLVED: To provide chimeric antigen receptors comprising ROR1 antigen binding domain, an...